Researchers Develop CRISPR-Based Test for Rapid Leukemia Diagnosis
Researchers have developed a CRISPR-based diagnostic test that accurately detects gene fusions in APL and CML within two hours.
Read MorePosted by Andy Lundin | Oct 9, 2024 | Leukemia |
Researchers have developed a CRISPR-based diagnostic test that accurately detects gene fusions in APL and CML within two hours.
Read MorePosted by Andy Lundin | Oct 7, 2024 | Disease States |
The Gazelle Hb Variant Test offers a faster, affordable alternative to traditional lab tests for sickle cell disease and beta thalassemia.
Read MorePosted by Andy Lundin | Sep 18, 2024 | Podcasts, Point-of-Care |
In this episode of Clinical Lab Chat, Seth Egan of Co-Diagnostics discusses how POC testing improves both diagnostic and treatment access.
Read MorePosted by Andy Lundin | Sep 18, 2024 | Dementias & Alzheimer’s |
Blood-based microRNA biomarkers can predict the progression of Alzheimer’s disease, offering a less invasive method for early diagnosis.
Read MorePosted by Chris Wolski | Sep 16, 2024 | Specimen Collection & Handling |
Truvian CEO Jay Srinivasan outlines how the company’s instrument could revolutionize blood testing at the point-of-care.
Read More